Edition:
United States

ContraFect Corp (CFRX.OQ)

CFRX.OQ on NASDAQ Stock Exchange Capital Market

2.52USD
1:39pm EDT
Change (% chg)

$-0.03 (-1.18%)
Prev Close
$2.55
Open
$2.55
Day's High
$2.74
Day's Low
$2.50
Volume
19,915
Avg. Vol
25,915
52-wk High
$2.75
52-wk Low
$0.80

Chart for

About

ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Its pipeline of lysin... (more)

Overall

Beta: -0.31
Market Cap(Mil.): $187.83
Shares Outstanding(Mil.): 73.66
Dividend: --
Yield (%): --

Financials

  CFRX.OQ Industry Sector
P/E (TTM): -- 235.76 33.88
EPS (TTM): -0.42 -- --
ROI: -84.96 -5.45 13.21
ROE: -216.98 -6.94 15.18

BRIEF-ContraFect Announces Q1 Loss Per Share $0.26

* CONTRAFECT - AS OF MARCH 31, 2018, HAD CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $39.9 MILLION, COMPARED TO $46.9 MILLION AS OF DECEMBER 31, 2017

May 10 2018

Earnings vs. Estimates